Suchergebnisse - (Person:"Liao, Xuejiao")

PubPharm (17)

11

Early Viral Clearance and Antibody Kinetics of COVID-19 Among Asymptomatic Carriers

enthalten in: Frontiers in medicine | 2021

von Xiao, T. | Wang, Y. | Yuan, J. | +8

12

The Transient IFN Response and the Delay of Adaptive Immunity Feature the Severity of COVID-19

enthalten in: Frontiers in immunology | 2021

von Xu, G. | Qi, F. | Wang, H. | +8

13

Viral RNA level, serum antibody responses, and transmission risk in recovered COVID-19 patients with recurrent positive SARS-CoV-2 RNA test results : a population-based observational cohort study

enthalten in: Emerging microbes & infections | 2020

von Yang, C. | Jiang, M. | Wang, X. | +32

14

Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2020

von Zhao, J. | Yuan, Q. | Wang, H. | +22

CommentIn: Clin Infect Dis. 2020 Jul 28;71(15):897. - PMID 32271865

15

Early Virus Clearance and Delayed Antibody Response in a Case of Coronavirus Disease 2019 (COVID-19) With a History of Coinfection With Human Immunodeficiency Virus Type 1 and Hepatitis C Virus

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2020

von Zhao, J. | Liao, X. | Wang, H. | +4

CommentIn: Clin Infect Dis. 2021 Jan 23;72(1):180-182. - PMID 32502247

16

Experimental Treatment with Favipiravir for COVID-19 : An Open-Label Control Study

enthalten in: Engineering (Beijing, China) | 2020

von Cai, Q. | Yang, M. | Liu, D. | +23

17

Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, Shenzhen, China, 2020

enthalten in: Emerging infectious diseases | 2020

von Liu, J. | Liao, X. | Qian, S. | +7